Vector BioPharma

Basel, Switzerland

Vector BioPharma's cutting-edge gene precision delivery technology will transform the safety, efficacy, and specificity of biologics.

$30.0M raised

Aug 2022

Series A

Biotechnology Life Science

Top Investors

Versant Ventures

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Vector BioPharma

How much funding has Vector BioPharma raised?

Vector BioPharma has raised $30.0M in total funding. The most recent round was Series A. The last funding was announced in August 2022.

Who are Vector BioPharma's investors?

Vector BioPharma's investors include Versant Ventures.

Where is Vector BioPharma headquartered?

Vector BioPharma is headquartered in Basel, Switzerland.

What does Vector BioPharma do?

Vector BioPharma's cutting-edge gene precision delivery technology will transform the safety, efficacy, and specificity of biologics.

What stage is Vector BioPharma at?

Vector BioPharma is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 10, 2022.

MLA

"Vector BioPharma — Funding & Investors." VCBacked, August 10, 2022, https://www.vcbacked.co/company/vector-biopharma. Accessed July 2, 2026.

APA

VCBacked. (2022). Vector BioPharma — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/vector-biopharma

Wikipedia (cite web)

{{cite web |title=Vector BioPharma — Funding & Investors |url=https://www.vcbacked.co/company/vector-biopharma |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 10, 2022.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K